- 101. albuminuria
- [presence of albumin in the urine; an indicator of kidney disease. ( CSP )] (UMLS (CSP) C0001925) =Finding ;
| - 151. Alcohol-induced mental disorders
- [ ] (UMLS (ICD9CM) C1456285) =Mental or Behavioral Dysfunction
|
- 102. albuterol
- [short-acting beta2-adrenergic agonist with its main clinical use in asthma. ( CSP )] (UMLS (CSP) C0001927) =Organic Chemical; Pharmacologic Substance
| - 152. Alcohol-Related Carcinoma
- (UMLS (NCI) C1332226) =Neoplastic Process ;
|
- 103. alcalase novo
- [ ] (UMLS (CSP) C0038597) =Amino Acid, Peptide, or Protein; Enzyme =Subtilisins;
[OP400] CONTACT LENS SOLUTIONS;
TO BE DELETED INGREDIENT PREPARATIONS;
=ENZYMATIC CLEANER (SUBTILISIN A) TAB,OPH,EFFERVSC;
ENZYMATIC CLEANER (ULTRAZYME) TAB,OPH,EFFERVSC | - 153. Alcohol-Related Esophageal Carcinoma
- (UMLS (NCI) C1332227) =Neoplastic Process ;
|
- 104. Alcaligenes
- [A genus of gram-negative, aerobic, motile bacteria that occur in water and soil. Some are common inhabitants of the intestinal tract of vertebrates. These bacteria occasionally cause opportunistic infections in humans. ( MSH )] (UMLS (CSP) C0001930) =Bacterium ;
| - 154. Alcohol-Related Hepatocellular Carcinoma
- (UMLS (NCI) C1332228) =Neoplastic Process ;
|
- 105. ALCASE
- [The Alliance for Lung Cancer Advocacy, Support and Education is a nonprofit organization based in Vancouver, Washington, founded to improve the quality of live of lung cancer patients through raising awareness of issues concerning lung cancer diagnosis and treatment; psychosocial support; and providing education. ( NCI )] (UMLS (NCI) C1510858) Alliance for Lung Cancer Advocacy Support and Education;
=Health Care Related Organization ;
| - 155. Alcohol-Related Laryngeal Carcinoma
- (UMLS (NCI) C1332229) =Neoplastic Process ;
|
- 106. ALCHL GASTRTIS W/O HMRHG
- [ ] (UMLS (ICD9CM) C0156077) =Disease or Syndrome
| - 156. Alcohol/drug treatment patient
- (UMLS (HL7) C1549591) =Intellectual Product =Confidentiality code;
|
- 107. ALCHL GSTRITIS W HMRHG
- [ ] (UMLS (ICD9CM) C0156078) =Disease or Syndrome
| - 157. alcoholic beverage
- [drinkable liquids containing ethanol. ( CSP )] (UMLS (CSP) C0001967) =Food ;
|
- 108. Alcian blue stain
- [Stain, Alcian blue ( HL7V3.0 )] (UMLS (HL7) C1293946) =Laboratory Procedure =ObservationMethod;
| - 158. Alcoholic Cardiomyopathy
- [A dilated cardiomyopathy which is associated with consumption of large amounts of alcohol over a period of years. ( NCI )] (UMLS (NCI) C0007192) =Disease or Syndrome =Alcohol-Induced Disorders;
cardiomyopathy |
- 109. Alcian blue with Periodic acid Schiff stain
- [Stain, Alcian blue with Periodic acid Schiff ( HL7V3.0 )] (UMLS (HL7) C1293965) =Laboratory Procedure =ObservationMethod;
| - 159. ALCOHOLIC FATTY LIVER
- [lipid infiltration and fatty degeneration of liver parenchymal cells due to alcohol abuse; may be associated with alcohol hepatitis or cirrhosis. ( CSP )] (UMLS (ICD9CM) C0015696) =Disease or Syndrome =fatty liver;
alcohol induced liver disorder |
- 110. ALCL
- [A rare aggressive form of lymphoma (cancer that begins in cells of the lymphatic system) that is usually of T-cell origin. ( NCI )] (UMLS (NCI) C0206180) =Neoplastic Process =histiocytic lymphoma;
CTCL | - 160. Alcoholic gastritis
- [ ] (UMLS (ICD9CM) C0156076) =Disease or Syndrome
|
- 111. Alcobon
- (UMLS (NCI) C0733923) Ancobon;
Ancotil;
=Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
| - 161. Alcoholic Hepatitis
- [acute or chronic degenerative and inflammatory lesion of the liver in the alcoholic which is potentially progressive though sometimes reversible; it does not necessarily include steatosis, fibrosis, or cirrhosis of the liver, although it is frequently associated with these conditions; it is characterized by liver cell necrosis, infiltration by polymorphonuclear leukocytes and lymphocytes, and Mallory bodies. ( CSP )] (UMLS (NCI) C0019187) =Disease or Syndrome ;
=hepatitis;
alcohol induced liver disorder |
- 112. ALCOH DEP NEC/NOS-CONTIN
- [ ] (UMLS (ICD9CM) C0154475) =Mental or Behavioral Dysfunction
| - 162. Alcoholics Anonymous
- [An organization of self-proclaimed alcoholics who meet frequently to reinforce their practice of abstinence. ( MSH )] (UMLS (CSP) C0001972) =Self-help or Relief Organization ;
|
- 113. ALCOH DEP NEC/NOS-EPISOD
- [ ] (UMLS (ICD9CM) C0154476) =Mental or Behavioral Dysfunction
| - 163. alcoholism chemotherapy
- [ ] (UMLS (CSP) C0920389) =Therapeutic or Preventive Procedure ;
|
- 114. ALCOH DEP NEC/NOS-REMISS
- [ ] (UMLS (ICD9CM) C0154477) =Mental or Behavioral Dysfunction
| - 164. ALCOHOLISM COUNSELLING
- (UMLS (ICD9CM) C0199404) =Therapeutic or Preventive Procedure
|
- 115. ALCOH DEP NEC/NOS-UNSPEC
- [ ] (UMLS (ICD9CM) C0154474) =Mental or Behavioral Dysfunction
| - 165. ALCOHOLISM IN FAMILY
- [ ] (UMLS (ICD9CM) C0476560) =Finding
|
- 116. ALCOH INDUCE SLEEP DISOR
- [ ] (UMLS (ICD9CM) C0236662) =Mental or Behavioral Dysfunction
| - 166. alcoholism information system
- [ ] (UMLS (CSP) C0920390) =Manufactured Object; Intellectual Product
|
- 117. ALCOH PSY DIS W HALLUCIN
- [ ] (UMLS (ICD9CM) C0302369) =Disease or Syndrome
| - 167. alcoholism pharmacotherapy
- [ ] (UMLS (CSP) C1330963) =Therapeutic or Preventive Procedure ;
|
- 118. ALCOH PSYCH DIS W DELUS
- [ ] (UMLS (ICD9CM) C0236658) =Mental or Behavioral Dysfunction
| - 168. alcoholism prevention
- [ ] (UMLS (CSP) C0920391) =Therapeutic or Preventive Procedure ;
|
- 119. alcohol
- [compounds of the type ROH; do not confuse with ETHANOL, the specific alcohol found in intoxicating beverages. ( CSP )] (UMLS (CSP) C0001975) =Organic Chemical; Pharmacologic Substance
| - 169. alcoholism therapy
- [ ] (UMLS (CSP) C0920392) =Therapeutic or Preventive Procedure ;
|
- 120. Alcohol
- (UMLS (HL7) C1547288) =Intellectual Product =Recreational Drug Use Code;
| - 170. alcoholism/alcohol abuse chemotherapy
- [application of the beneficial effects of drugs to control or cure alcoholism or alcohol abuse. ( CSP )] (UMLS (CSP) C0596060) =Therapeutic or Preventive Procedure ;
=chemotherapy;
alcoholism/alcohol abuse therapy |
- 121. alcohol abstinence
- [ ] (UMLS (CSP) C0678274) =Individual Behavior ;
| - 171. alcoholism/alcohol abuse information system
- [integrated set of files, procedures, and equipment for the storage, manipulation, and retrieval of information on alcohol, alcoholism, alcohol abuse and may include therapies, treatments, education, etc.; also used to cover the concept of alcoholism or alcohol abuse databases. ( CSP )] (UMLS (CSP) C0596062) =Manufactured Object; Intellectual Product =information system;
|
- 122. alcohol abuse
- [The use of alcoholic beverages to excess, either on individual occasions ("binge drinking") or as a regular practice. ( NCI )] (UMLS (CSP) C0085762) =Mental or Behavioral Dysfunction ;
| - 172. alcoholism/alcohol abuse prevention
- [increasing the awareness of alcoholism or alcohol abuse, prevention of the disease in susceptible individuals or populations through promotion of health, including mental health, and prevention of complications or after-effects of existing disease; this concept may overlap with ALCOHOLISM/ALCOHOL ABUSE EDUCATION. ( CSP )] (UMLS (CSP) C0596063) =Therapeutic or Preventive Procedure ;
=drug abuse prevention;
=alcohol abuse education;
|
- 123. alcohol abuse chemotherapy
- [ ] (UMLS (CSP) C0920385) =Therapeutic or Preventive Procedure ;
| - 173. alcoholism/alcohol abuse therapy
- [treatments alone or in combination for alcohol abuse or alcoholism or related disorders; including but not limited to, drug therapy, behavioral therapy, psychotherapy, aversion therapy, alternative medicine, group counseling. ( CSP )] (UMLS (CSP) C0596064) =Therapeutic or Preventive Procedure ;
=Therapeutic Interventions;
=alcoholism/alcohol abuse chemotherapy;
|
- 124. alcohol abuse education
- [instruction or training that encourages behaviors most likely to optimize health potentials through information about alcoholism and alcohol abuse; facilitates the prevention of alcoholism and alcohol abuse, frequently for those who are at risk; also includes instruction or training that increases the awareness and favorably influences the attitudes and knowledge about alcoholism and alcohol abuse on a personal or community basis; it also includes the training of medical personnel about alcoholism and alcohol abuse for prevention or treatment programs, for this type of alcoholism and alcohol abuse education postcoordinate with the appropriate health professional education term; this concept may overlap with ALCOHOLISM/ ALCOHOL ABUSE PREVENTION. ( CSP )] (UMLS (CSP) C0871642) alcoholism education;
alcoholism/alcohol abuse education =Educational Activity ;
=alcoholism/alcohol abuse prevention;
drug abuse education | - 174. Aldactone
- (UMLS (NCI) C0591054) =Steroid; Pharmacologic Substance
|
- 125. alcohol abuse information system
- [ ] (UMLS (CSP) C0920386) =Manufactured Object; Intellectual Product
| - 175. Aldara
- (UMLS (NCI) C0718327) =Organic Chemical; Pharmacologic Substance ;
|
- 126. alcohol abuse pharmacotherapy
- [ ] (UMLS (CSP) C1330962) =Therapeutic or Preventive Procedure; ;
| - 176. aldehyde
- [organic compounds containing a carbonyl group in the form -CHO. ( CSP )] (UMLS (CSP) C0001992) =Organic Chemical ;
|
- 127. alcohol abuse prevention
- [ ] (UMLS (CSP) C1171178) =Therapeutic or Preventive Procedure ;
| - 177. aldehyde dehydrogenase
- [ ] (UMLS (CSP) C0684287) =Amino Acid, Peptide, or Protein; Enzyme ;
=aldehyde/ketone oxidoreductase;
|
- 128. alcohol abuse therapy
- [ ] (UMLS (CSP) C0920388) =Therapeutic or Preventive Procedure ;
| - 178. Aldehyde Dehydrogenase 1 Family Member A2
- [Encoded by human ALDH1A2 Gene, Aldehyde Dehydrogenase 1A2 (ADH Family) is a 499-amino acid 54.8 kD putative cytoplasmic homotetrameric NAD-dependent retinaldehyde dehydrogenase, similar to class 1 aldehyde dehydrogenases that synthesizes retinoic acid from retinaldehyde. The protein contains conserved aldehyde dehydrogenase motifs: GXGXXXG motif NAD-binding domain, two peptide motifs, and cys301, critical for aldehyde group interaction. ALDH1A2 and CYP26A1 regulate local retinoic acid levels that act as a signal in developing and adult tissues; CYP26A1 metabolizes retinoic acid. In T-ALL, ectopically expressed TAL1 and LMO in T cells form a complex with GATA3 on the RALDH2-T promoter and activate transcription. (OMIM, Swiss-Prot, and NCI) ( NCI )] (UMLS (NCI) C0752609) Aldehyde Dehydrogenase 1 Family, Member A2;
Aldehyde Dehydrogenase 1A2;
ALDH1A2;
RALDH(II);
RALDH2;
RALDH-2;
Retinaldehyde-Specific Dehydrogenase Type 2 =Amino Acid, Peptide, or Protein; Enzyme |
- 129. Alcohol abuse, continuous drinking behavior
- [ ] (UMLS (ICD9CM) C1812624) ALCOHOL ABUSE-CONTINUOUS =Mental or Behavioral Dysfunction ;
| - 179. Aldehyde Dehydrogenase 1 Family, Member A2 Gene
- [This gene plays a role in biosynthesis, cell differentiation and intercellular communication. ( NCI )] (UMLS (NCI) C1332076) ALDH1A2;
ALDH1A2 Gene;
=Gene or Genome |
- 130. Alcohol abuse, episodic drinking behavior
- [ ] (UMLS (ICD9CM) C0154515) =Mental or Behavioral Dysfunction
| - 180. aldehyde lyase
- [Enzymes that catalyze a reverse aldol condensation. A molecule containing a hydroxyl group and a carbonyl group is cleaved at a C-C bond to produce two smaller molecules (ALDEHYDES or KETONES). EC 4.1.2. ( MSH )] (UMLS (CSP) C0001990) =Amino Acid, Peptide, or Protein; Enzyme
|
- 131. Alcohol abuse, in remission
- [ ] (UMLS (ICD9CM) C0154516) =Mental or Behavioral Dysfunction
| - 181. aldehyde oxidase
- [An aldehyde oxidoreductase expressed predominantly in the LIVER; LUNGS; and KIDNEY. It catalyzes the oxidation of a variety of organic aldehydes and N-heterocyclic compounds to CARBOXYLIC ACIDS, and also oxidizes QUINOLINE and PYRIDINE derivatives. The enzyme utilizes molybdenum cofactor and FAD as cofactors. ( MSH )] (UMLS (CSP) C0051124) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 132. Alcohol affecting fetus or newborn via placenta or breast milk
- [disorder occurring in children born to alcoholic women who continue to drink heavily during pregnancy; common abnormalities are growth deficiency (prenatal and postnatal), altered morphogenesis, mental deficiency, and characteristic facies - small eyes and flattened nasal bridge; fine motor dysfunction and tremulousness are observed in the newborn. ( CSP )] (UMLS (ICD9CM) C0015923) =Disease or Syndrome ;
=embryo/fetus disorder;
syndrome;
Alcohol-Induced Disorders;
| - 182. aldehyde reductase
- [aldose reductase converts glucose to sorbitol, mediating sorbitol toxicity (neuropathy and retinopathy) in diabetes mellitus do not confuse with EC 1.1.1.1, ALCOHOL DEHYDROGENASE. ( CSP )] (UMLS (CSP) C0002003) =Amino Acid, Peptide, or Protein; Enzyme
|
- 133. Alcohol and drug rehabilitation and detoxification
- [ ] (UMLS (ICD9CM) C0178073) =Therapeutic or Preventive Procedure
| - 183. aldehyde/ketone oxidoreductase
- [ ] (UMLS (CSP) C0596065) =Amino Acid, Peptide, or Protein; Enzyme =dehydrogenase;
=glyceraldehyde 3 phosphate dehydrogenase;
alpha ketoglutarate dehydrogenase;
pyruvate dehydrogenase;
pyruvate oxidase;
aldehyde dehydrogenase;
|
- 134. ALCOHOL CIRRHOSIS LIVER
- [liver disease in alcoholics in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. ( CSP )] (UMLS (ICD9CM) C0023891) =Disease or Syndrome ;
=cirrhosis;
alcohol induced liver disorder | - 184. aldolase
- [An enzyme of the lyase class that catalyzes the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on (3S,4R)-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. (Enzyme Nomenclature, 1992) E.C. 4.1.2.13. ( MSH )] (UMLS (CSP) C0016762) =Amino Acid, Peptide, or Protein; Enzyme
|
- 135. Alcohol Consumption
- [consumption of liquids containing ethanol; includes the behavior of drinking the alcohol. ( CSP )] (UMLS (NCI) C0001948) =Individual Behavior ;
| - 185. Aldomet
- (UMLS (NCI) C0591055) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 136. alcohol dehydrogenase
- [also another name for EC 1.1.1.21, ALDEHYDE REDUCTASE, do not confuse. ( CSP )] (UMLS (CSP) C0001942) =Amino Acid, Peptide, or Protein; Enzyme
| - 186. aldosterone hypertension
- [ ] (UMLS (CSP) C0920393) =Pathologic Function ;
|
- 137. ALCOHOL DETOXIFICATION
- [ ] (UMLS (ICD9CM) C0204597) =Therapeutic or Preventive Procedure
| - 187. aldosterone inhibitor
- [agent that counteracts or opposes the action of aldosterone. ( CSP )] (UMLS (CSP) C0002007) =Pharmacologic Substance
|
- 138. alcohol induced liver disorder
- [Liver diseases associated with ALCOHOLISM. It usually refers to the coexistence of two or more subentities, i.e., ALCOHOLIC FATTY LIVER; ALCOHOLIC HEPATITIS; and ALCOHOLIC CIRRHOSIS. ( MSH )] (UMLS (CSP) C0023896) =Disease or Syndrome ;
=Hepatic Disorder;
Alcohol-Induced Disorders =ALCOHOLIC FATTY LIVER;
Alcoholic Hepatitis;
ALCOHOL CIRRHOSIS LIVER;
| - 188. aldosterone receptor
- [Cytoplasmic proteins that specifically bind aldosterone and mediate its cellular effects. The aldosterone-bound receptor acts in the nucleus to regulate the transcription of specific segments of DNA. ( MSH )] (UMLS (CSP) C0051133) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 139. alcohol influenced driving
- [operating a vehicle (automobile, truck, boat, plane, bicycle, etc) while under the influence of alcohol or other illicit drugs. ( CSP )] (UMLS (CSP) C0556374) =Mental or Behavioral Dysfunction ;
=Abuso cronico de alcool;
legal/correctional;
substance abuse related behavior;
| - 189. Aldosterone Receptor
- [Highly expressed as 4 alternative isoforms in kidney and sweat glands by human NR3C2 Gene (NR3 Family), ubiquitous phosphorylated Mineralocorticoid Receptor contains an N-terminal modulating domain, a DNA-binding domain, and a C-terminal steroid (mineralocorticoid/glucocorticoid)-binding domain. Absent ligand, NR3C2 resides in a heteromultimeric cytoplasmic complex with HSP90, HSP70, and FKBP4 or with HSD11B2 in the ER membrane. Ligand-activated NR3C2 translocates to the nucleus, binds to DNA mineralocorticoid response elements as a homodimer or heterodimer with NR3C1, and transactivates target gene expression, which increases ion and water transport; raises extracellular fluid volume and blood pressure; and lowers potassium levels. NR3C2 appears to bind NCOA1, NCOA2, TIF1, and NRIP1. NR3C2 defects cause PHA1 and early onset hypertension. (NCI) ( NCI )] (UMLS (NCI) C0066563) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 140. Alcohol Intoxication
- [An acute brain syndrome which results from the excessive ingestion of ETHANOL or ALCOHOLIC BEVERAGES. ( MSH )] (UMLS (NCI) C0001969) =Mental or Behavioral Dysfunction ;
| - 190. aldosterone stimulant
- [ ] (UMLS (CSP) C0599480) =Steroid; Pharmacologic Substance; Hormone
|
- 141. ALCOHOL LIVER DAMAGE NOS
- [ ] (UMLS (ICD9CM) C1442981) Alcoholic liver damage, unspecified;
=Disease or Syndrome ;
| - 191. aldosteronism
- [abnormality of electrolyte function caused by excessive secretion of aldosterone by the adrenal cortex. ( CSP )] (UMLS (CSP) C0020428) =Disease or Syndrome =adrenal disorder;
Adrenal Gland Hyperfunction =Bartter's Disease;
CONN'S SYNDROME;
Bartter's Disease;
|
- 142. ALCOHOL MENTAL DISOR NEC
- [ ] (UMLS (ICD9CM) C1456283) Other specified alcohol-induced mental disorders;
=Mental or Behavioral Dysfunction | - 192. Aldrich syndrome
- [rare x-linked immunodeficiency syndrome of young boys characterized by eczema, thrombocytopenic purpura and recurrent pyogenic infection; IGM levels are low and IGA and IGE levels are elevated; lymphoreticular malignancies are common. ( CSP )] (UMLS (CSP) C0043194) =Disease or Syndrome ;
=HEMORRHAGIC COND NOS;
Genetic Condition;
hypoimmunity;
Congenital anomalies of the integument;
syndrome;
thrombocytopenia;
inborn immunodeficiency;
Purpura, Thrombocytopenic |
- 143. ALCOHOL MENTAL DISOR NOS
- [acute and chronic mental disorders characterized by gross impairment in reality perception due to alcoholism; evidenced by delusions, hallucinations, markedly incoherent speech or disorganized and agitated behavior; includes alcohol withdrawal seizures and delirium, alcohol amnestic disorder and alcoholic neuropathies. ( CSP )] (UMLS (ICD9CM) C0033936) =Mental or Behavioral Dysfunction =Abuso cronico de alcool;
Psychoses, Substance-Induced;
PSYCHOSES;
Alcohol-Induced Disorders =Korsakoff Syndrome;
| - 193. aldrin
- [A highly poisonous substance that was formerly used as an insecticide. The manufacture and use has been discontinued in the U.S. (From Merck Index, 11th ed) ( MSH )] (UMLS (CSP) C0002011) =Organic Chemical; Hazardous or Poisonous Substance ;
|
- 144. alcohol oxidoreductase
- [A subclass of enzymes which includes all dehydrogenases acting on primary and secondary alcohols as well as hemiacetals. They are further classified according to the acceptor which can be NAD+ or NADP+ (subclass 1.1.1), cytochrome (1.1.2), oxygen (1.1.3), quinone (1.1.5), or another acceptor (1.1.99). ( MSH )] (UMLS (CSP) C0001954) =Amino Acid, Peptide, or Protein; Enzyme
| - 194. Alemtuzumab
- [A monoclonal antibody used to treat leukemia. Monoclonal antibodies are made in the laboratory. They can find cancer cells and bind to them. Also called Campath-1H. ( NCI )] (UMLS (NCI) C0383429) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =[AN000] ANTINEOPLASTICS;
Unclassified Ingredients =ALEMTUZUMAB 10 MG/ML |
- 145. ALCOHOL PERSIST DEMENTIA
- [ ] (UMLS (ICD9CM) C0236656) =Mental or Behavioral Dysfunction
| - 195. Alemtuzumab/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine
- (UMLS (NCI) C1328084) =Therapeutic or Preventive Procedure ;
|
- 146. alcohol phosphotransferase
- [ ] (UMLS (CSP) C0596059) =Amino Acid, Peptide, or Protein; Enzyme =EC 2.7;
=adenosine kinase;
galactokinase;
glucokinase;
glycerol kinase;
hexokinase;
EC 2.7.1.117;
6 phosphofructokinase;
PKC;
EC 2.7.1.37;
phosphoenol transphosphorylase;
EC 2.7.1.21;
1-Phosphatidylinositol 3-Kinase;
beta adrenergic receptor kinase;
casein kinase;
endogenous substrate pp120;
NAD kinase;
opsin kinase;
EC 2.7.2- | - 196. Alemtuzumab/Cyclophosphamide/Fludarabine
- (UMLS (NCI) C1134603) =Therapeutic or Preventive Procedure
|
- 147. ALCOHOL REHAB/DETOX
- [ ] (UMLS (ICD9CM) C0204599) =Therapeutic or Preventive Procedure
| - 197. Alemtuzumab/Fludarabine
- (UMLS (NCI) C1327792) =Therapeutic or Preventive Procedure ;
|
- 148. ALCOHOL REHABILITATION
- [ ] (UMLS (ICD9CM) C0204598) =Therapeutic or Preventive Procedure
| - 198. Alemtuzumab/Fludarabine/Melphalan
- (UMLS (NCI) C1134523) =Therapeutic or Preventive Procedure
|
- 149. ALCOHOL WITHDRAWAL
- [ ] (UMLS (ICD9CM) C0236663) =Disease or Syndrome
| - 199. ALENDRONATE SODIUM
- [A drug that affects bone metabolism. It is used in treating osteoporosis and Paget's disease, and is being studied in the treatment of hypercalcemia (abnormally high levels of calcium in the blood) and in treating and reducing the risk of bone pain caused by cancer. Alendronate sodium belongs to the family of drugs called bisphosphonates. ( NCI )] (UMLS (NCI) C0700482) =Organophosphorus Compound; Pharmacologic Substance
|
- 150. Alcohol withdrawal delirium
- [An acute organic mental disorder induced by cessation or reduction in chronic alcohol consumption. Clinical characteristics include CONFUSION; DELUSIONS; vivid HALLUCINATIONS; TREMOR; agitation; insomnia; and signs of autonomic hyperactivity (e.g., elevated blood pressure and heart rate, dilated pupils, and diaphoresis). This condition may occasionally be fatal. It was formerly called delirium tremens. (From Adams et al., Principles of Neurology, 6th ed, p1175) ( MSH )] (UMLS (ICD9CM) C0001957) =Disease or Syndrome ;
| - 200. Alendronate Sodium/Ketoconazole
- (UMLS (NCI) C0796551) KCZ/MK-217 =Therapeutic or Preventive Procedure
|
home
